BioSpace News Archive

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against electroCore, Inc..

Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company that is pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein expression, today announced the closing of its initial public offering of 9,074,776 shares of its common stock at a price to the public of $18.00

The HYPERSOMNIA FOUNDATION (HF), a leading nonprofit patient advocacy group dedicated to improving the lives of people with idiopathic hypersomnia and other rare sleep disorders, will be holding a Hypersomnia Educational Meeting in Seattle, WA on June 29, 2019.

The U.S. Food and Drug Administration today approved Vyleesi (bremelanotide) to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.

Palatin Technologies, Inc. (NYSE American: PTN) announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval of AMAG Pharmaceuticals, Inc.'s New Drug Application (NDA) for Vyleesi

Arrowhead Pharmaceuticals Inc. announced that as an inducement to entering into employment with the Company, on June 14, 2019, the Compensation Committee of the Board of Directors approved “inducement” grants to 11 new employees under Rule 5635 of the NASDAQ Marketplace Rules.

Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today commented on the final updated U.S. Centers for Medicare and Medicaid Services (CMS) national coverage determination (NCD) pertaining to transcatheter aortic valve replacement (TAVR) programs:

ALKU, a highly specialized consulting services firm will be exhibiting at DIA 2019 Global Annual Meeting June 23rd27th, at booth #2638

A new peer-reviewed study envisioned by Ashley Black, was released from the Cogent Medicine Journal highlighting the positive effects that fascia manipulation protocols and devices had on a group of select women.

Fujifilm will present its cardiovascular medical imaging portfolio including Synapse Cardiology PACS with Epsilon Imaging’s EchoInsight, as well as the SonoSite Edge II point-of-care-ultrasound system (POCUS) at the American Society of Echocardiography annual meeting (ASE 2019).